Xtant Medical Holdings, Inc.
XTNT
$0.54
-$0.01-1.47%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 130.23% | 109.96% | -37.41% | -621.48% | -2,592.27% |
| Total Depreciation and Amortization | 23.65% | 11.21% | 14.37% | 15.78% | 33.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.97% | 3.54% | 164.80% | 165.22% | 158.45% |
| Change in Net Operating Assets | 43.05% | 23.93% | 47.23% | 43.88% | -47.19% |
| Cash from Operations | 205.46% | 158.11% | 109.63% | 62.66% | -25.02% |
| Capital Expenditure | 42.09% | 30.10% | -125.33% | -155.56% | -182.49% |
| Sale of Property, Plant, and Equipment | -39.43% | -18.80% | -1.98% | 38.91% | 118.86% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 311.77% | 148.43% | 50.31% | 47.75% | 84.95% |
| Total Debt Issued | -14.94% | -9.09% | -1.54% | 21.90% | 41.36% |
| Total Debt Repaid | -3.98% | -10.14% | -10.68% | -25.26% | -36.56% |
| Issuance of Common Stock | -- | -100.00% | -68.10% | -68.10% | -68.10% |
| Repurchase of Common Stock | 29.21% | 26.98% | 20.14% | 38.85% | 31.80% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 82.49% | 94.14% | 88.71% | 60.79% | -172.38% |
| Cash from Financing | -159.54% | -139.89% | -83.04% | -50.86% | -18.37% |
| Foreign Exchange rate Adjustments | 255.70% | -224.32% | -194.59% | -308.00% | -720.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,627.18% | 313.77% | 51.36% | 203.18% | 102.04% |